Market revenue in 2020 | USD 225.8 million |
Market revenue in 2028 | USD 522.9 million |
Growth rate | 11.1% (CAGR from 2020 to 2028) |
Largest segment | Oral |
Fastest growing segment | Injectable |
Historical data covered | 2017 - 2019 |
Base year for estimation | 2020 |
Forecast period covered | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Topical, Injectable, Oral |
Key market players worldwide | Pfizer Inc, Sanofi SA, AbbVie Inc, Galderma Group AG Registered Shares, Eli Lilly and Co, Regeneron Pharmaceuticals Inc, Otsuka Holdings Co Ltd, Novartis AG ADR, Incyte Corp, LEO Pharma |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to atopic dermatitis drugs market will help companies and investors design strategic landscapes.
Oral was the largest segment with a revenue share of 46.94% in 2020. Horizon Databook has segmented the Middle East & Africa atopic dermatitis drugs market based on topical, injectable, oral covering the revenue growth of each sub-segment from 2017 to 2028.
The Middle East & African (MEA) countries, such as South Africa, Saudi Arabia, and the UAE, are prospering economies. The market in this region is driven by moderate prevalence of skin diseases, rise in consumer awareness, and improvements in healthcare infrastructure. Thus, MEA is a largely untapped market for atopic dermatitis treatments.
Economic development witnessed in emerging markets, such as South Africa, and high unmet healthcare needs are some of the primary growth drivers of this market. There is a high prevalence of communicable & infectious diseases in this region, which makes patients with skin diseases such as atopic dermatitis susceptible to infections, thereby making treatment crucial.
However, poor infrastructure and affordability might hamper the market in this region. Growing healthcare awareness, increasing initiatives undertaken by various NGOs, improved penetration of health insurance policies, and privatization are some of the factors anticipated to fuel the market in this region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa atopic dermatitis drugs market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa atopic dermatitis drugs market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account